OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis

Journal of the American Academy of Dermatology

Volumn 68, Issue 5, 2013, Pages 756-764

  Kimball, Alexa B ^a   Pariser, David ^b   Yamauchi, Paul S ^c   Menter, Alan ^d   Teller, Craig F ^e   Shi, Yifei ^f   Yong, Mellissa ^f   Creamer, Kara ^f   Hooper, Michele ^f   Aras, Girish ^f   Kricorian, Gregory ^f   Gelfand, Joel M ^g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Skin Care Center   (United States)

^d BAYLOR RESEARCH INSTITUTE   (United States)

^e Bellaire Dermatology Associates   (United States)

^f AMGEN INC   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

etanercept; infections; lymphoma; nonmelanoma skin cancer; psoriasis; registry; safety

Indexed keywords

ETANERCEPT;

ABDOMINAL PAIN; ADULT; AGED; ALCOHOLIC PANCREATITIS; ANGINA PECTORIS; ARTICLE; ASPHYXIA; BLADDER CANCER; CELLULITIS; CHILD; CHOLECYSTITIS; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CRUSHING INJURY OF TRUNK; DEHYDRATION; DEMYELINATING DISEASE; DIVERTICULITIS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOXICITY; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GENERALIZED EDEMA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEPATIC ENCEPHALOPATHY; HUMAN; INJURY; INTERVERTEBRAL DISK HERNIA; LARGE CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; LUNG CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NEPHROLITHIASIS; OSTEOARTHRITIS; OSTEOMYELITIS; PANCREATITIS; PNEUMONIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RESPIRATORY FAILURE; SCHOOL CHILD; SEPSIS; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; SUICIDE; TRAFFIC ACCIDENT;

ADULT; AGED; CANADA; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PRODUCT SURVEILLANCE, POSTMARKETING; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; UNITED STATES;

EID: 84876408408     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.10.055     Document Type: Article

References (18)

1. J.M. Gelfand, S.R. Feldman, R.S. Stern, J. Thomas, T. Rolstad, and D.J. Margolis Determinants of quality of life in patients with psoriasis: a study from the US population J Am Acad Dermatol 51 2004 704 708
2. S.K. Kurd, and J.M. Gelfand The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004 J Am Acad Dermatol 60 2009 218 224
3. American Academy of Dermatology Work Group A. Menter, N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, and K.B. Gordon Guidelines of care for the management of psoriasis and psoriatic arthritis, section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions J Am Acad Dermatol 65 2011 137 174
4. Enbrel (etanercept) [full prescribing information] 2011 Immunex Corp Thousand Oaks, CA
5. C.L. Leonardi, J.L. Powers, R.T. Matheson, B.S. Goffe, R. Zitnik, and A. Wang Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2003 2014 2022
6. K.A. Papp, S. Tyring, M. Lahfa, J. Prinz, C.E. Griffiths, and A.M. Nakanishi A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction Br J Dermatol 152 2005 1304 1312
7. S. Tyring, A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, and A. Wang Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial Lancet 367 2006 29 35
8. K.B. Gordon, A.B. Gottlieb, C.L. Leonardi, B.E. Elewski, A. Wang, and A. Jahreis Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy J Dermatolog Treat 17 2006 9 17
9. A.B. Gottlieb, R.T. Matheson, N. Lowe, G.G. Krueger, S. Kang, and B.S. Goffe A randomized trial of etanercept as monotherapy for psoriasis Arch Dermatol 139 2003 1627 1632
10. C. Leonardi, B. Strober, A.B. Gottlieb, B.E. Elewski, J.P. Ortonne, and P. van de Kerkhof Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study J Drugs Dermatol 9 2010 928 937
11. S. Tyring, K.B. Gordon, Y. Poulin, R.G. Langley, A.B. Gottlieb, and M. Dunn Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis Arch Dermatol 143 2007 719 726
12. A.B. Kimball, D. Pariser, P.S. Yamauchi, A. Menter, C.F. Teller, and Y. Shi OBSERVE-5, an observational post-marketing safety surveillance registry of etanercept for the treatment of psoriasis: a model for studying new psoriasis therapies Psoriasis Forum 16 2010 3 7
13. M. Yong, J. Schenfeld, K. Creamer, Y. Shi, G. Aras, and M. Anthony External comparator data for the observational post-marketing safety surveillance registry of Enbrel (etanercept) for the treatment of psoriasis-a single-arm registry study [abstract] Pharmacoepidemiol Drug Saf 20 Suppl S1 2011 S228
14. Yong M, Schenfeld J, Anthony M, Kimball AB. Incidence rates of malignancies and hospitalized infectious events in psoriasis patients with or without treatment and a general population in the US: 2005-2009. Accepted poster presented at: American Academy of Dermatology 70th Annual Meeting; March 16-20, 2012; San Diego, CA.
15. K.D. Lindsted, G.E. Fraser, M. Steinkohl, and W.L. Beeson Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study J Clin Epidemiol 49 1996 783 790
16. P.F. Pinsky, A. Miller, B.S. Kramer, T. Church, D. Reding, and P. Prorok Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial Am J Epidemiol 165 2007 874 881
17. D.M. Pariser, C.L. Leonardi, K. Gordon, A.B. Gottlieb, S. Tyring, and K.A. Papp Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis J Am Acad Dermatol 67 2012 245 256
18. D. Aletaha, F. Alasti, and J.S. Smolen Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression Ann Rheum Dis 70 2011 1975 1980